MeSH term
Frequency | Condition_Probility | 1-Phosphatidylinositol 3-Kinase/metabolism | 3 | 0.0 |
Amino Acid Sequence | 22 | 0.0 |
Animals | 74 | 0.0 |
B-Lymphocytes/*immunology | 4 | 0.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Cell Line | 28 | 0.0 |
Phosphoproteins/*metabolism | 4 | 0.0 |
Phosphorylation | 52 | 0.0 |
Phosphotyrosine/metabolism | 6 | 1.0 |
Protein-Tyrosine Kinase/deficiency/genetics/*metabolism | 2 | 15.0 |
Receptors, Antigen, T-Cell/chemistry/*metabolism | 2 | 15.0 |
Research Support, Non-U.S. Gov't | 101 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 73 | 0.0 |
Signal Transduction/*physiology | 7 | 0.0 |
Cytokines/genetics | 2 | 1.0 |
DNA Primers | 5 | 0.0 |
Enzyme Activation | 25 | 0.0 |
Humans | 109 | 0.0 |
Mice | 39 | 0.0 |
Mice, Transgenic | 6 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 17 | 1.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 6 | 0.0 |
Enzyme Inhibitors/pharmacology | 11 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors/*metabolism | 3 | 5.0 |
Receptors, Fc/*metabolism | 3 | 8.0 |
Signal Transduction | 25 | 0.0 |
Models, Molecular | 5 | 0.0 |
Molecular Sequence Data | 26 | 0.0 |
Protein Binding | 17 | 0.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
*src Homology Domains | 3 | 1.0 |
COS Cells | 8 | 0.0 |
Calcium/metabolism | 9 | 0.0 |
DNA, Complementary/metabolism | 4 | 0.0 |
Flow Cytometry | 4 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
Ligands | 5 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Precipitin Tests | 9 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 5 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Time Factors | 7 | 0.0 |
Transfection | 11 | 0.0 |
src Homology Domains | 10 | 1.0 |
src-Family Kinases/*metabolism | 23 | 14.0 |
Female | 4 | 0.0 |
Gene Expression | 4 | 0.0 |
Male | 5 | 0.0 |
Mice, Knockout | 8 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 3 | 2.0 |
*Signal Transduction | 16 | 0.0 |
Adult | 6 | 0.0 |
In Vitro | 6 | 0.0 |
N-Formylmethionine Leucyl-Phenylalanine/pharmacology | 2 | 0.0 |
Phosphoproteins/isolation & purification/metabolism | 3 | 8.0 |
Solubility | 3 | 0.0 |
Tyrosine/*metabolism | 4 | 1.0 |
src-Family Kinases/metabolism | 15 | 8.0 |
Cell Differentiation | 7 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Interleukin-5/*pharmacology | 2 | 6.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Protein-Tyrosine Kinase/physiology | 3 | 2.0 |
*Proto-Oncogene Proteins | 5 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Blood Proteins/*chemistry | 2 | 7.0 |
CHO Cells | 3 | 0.0 |
Dose-Response Relationship, Drug | 6 | 0.0 |
Erythrocytes/metabolism | 2 | 1.0 |
Hamsters | 4 | 0.0 |
Kinetics | 11 | 0.0 |
Lipids/metabolism | 3 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Cell Adhesion | 5 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Isoenzymes/metabolism | 3 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Mutation | 7 | 0.0 |
Phospholipase C/metabolism | 3 | 1.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 3 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 12 | 0.0 |
Tumor Cells, Cultured | 22 | 0.0 |
U937 Cells | 2 | 0.0 |
Dimerization | 3 | 0.0 |
Monocytes/*metabolism | 2 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
*Apoptosis | 3 | 0.0 |
Blotting, Western | 11 | 0.0 |
Models, Biological | 5 | 0.0 |
NADPH Oxidase/*metabolism | 2 | 4.0 |
Phosphoric Monoester Hydrolases/*metabolism | 2 | 2.0 |
Receptors, IgG/*physiology | 2 | 6.0 |
Stilbenes/pharmacology | 3 | 9.0 |
Lymphocyte Activation | 7 | 0.0 |
Base Sequence | 12 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Chickens | 6 | 0.0 |
DNA Damage | 2 | 0.0 |
Hela Cells | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
src-Family Kinases/genetics/*metabolism | 2 | 9.0 |
Antibody Formation | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Models, Immunological | 2 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Receptors, Antigen, B-Cell/immunology | 2 | 8.0 |
X Chromosome/genetics | 2 | 1.0 |
src-Family Kinases/physiology | 3 | 9.0 |
Actins/metabolism | 2 | 0.0 |
Cytoskeleton/metabolism | 3 | 1.0 |
*Cell Adhesion Molecules | 2 | 0.0 |
*Lectins | 2 | 1.0 |
Enzyme Precursors/metabolism | 12 | 8.0 |
Proto-Oncogene Proteins/metabolism | 8 | 0.0 |
Rats | 10 | 0.0 |
B-Lymphocytes/*enzymology | 2 | 10.0 |
3T3 Cells | 2 | 0.0 |
Comparative Study | 6 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/genetics/*metabolism | 2 | 11.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 4 | 0.0 |
src-Family Kinases/*blood | 2 | 100.0 |
src-Family Kinases/*genetics | 2 | 40.0 |
Blotting, Northern | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Mitogen-Activated Protein Kinase 9 | 2 | 6.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Nerve Tissue Proteins/*metabolism | 2 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Enzyme Activation/drug effects | 5 | 0.0 |
Exocytosis/drug effects | 2 | 9.0 |
Genistein/pharmacology | 2 | 1.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Phosphorylation/drug effects | 4 | 0.0 |
src-Family Kinases/*physiology | 3 | 7.0 |
Calcium/*physiology | 2 | 1.0 |
Enzyme Precursors/physiology | 3 | 21.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
Chromosomes, Human, Pair 8 | 2 | 1.0 |
Gene Expression Profiling | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Binding Sites | 9 | 0.0 |
Enzyme Precursors/*metabolism | 3 | 2.0 |
Protein-Tyrosine Kinase/*metabolism | 17 | 2.0 |
Substrate Specificity | 4 | 0.0 |
Platelet Aggregation/drug effects | 2 | 0.0 |
Signal Transduction/*drug effects | 3 | 0.0 |
Apoptosis/*physiology | 3 | 0.0 |
*Protein Processing, Post-Translational | 3 | 1.0 |
Protein-Tyrosine Kinase/*physiology | 4 | 2.0 |
Tyrosine/metabolism | 7 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Receptors, IgE/analysis/*metabolism | 2 | 100.0 |
Quinones/pharmacology | 3 | 2.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
Integrins/metabolism | 2 | 1.0 |
Phagocytosis | 2 | 0.0 |
Tyrosine | 2 | 1.0 |
Platelet Activation/*physiology | 2 | 3.0 |
Cell Line, Transformed | 2 | 0.0 |
Spodoptera | 2 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Blood Platelets/*metabolism | 2 | 0.0 |
Receptor Aggregation | 2 | 2.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
GTPase-Activating Proteins | 2 | 1.0 |
Proteins/*metabolism | 3 | 0.0 |
Down-Regulation | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/*metabolism | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Antineoplastic Agents/*pharmacology/therapeutic use | 2 | 2.0 |
Cell Division/drug effects | 2 | 0.0 |
src-Family Kinases/*antagonists & inhibitors | 2 | 12.0 |
B-Lymphocytes/*enzymology/immunology | 2 | 28.0 |
Enzyme Precursors/immunology/*metabolism | 2 | 50.0 |
Protein-Tyrosine Kinase/immunology/*metabolism | 4 | 21.0 |
Signal Transduction/immunology | 2 | 0.0 |
src-Family Kinases/immunology/*metabolism | 2 | 100.0 |
GTP-Binding Proteins/metabolism | 2 | 0.0 |
Enzyme Activation/genetics/immunology | 2 | 10.0 |
Protein Binding/immunology | 2 | 1.0 |
Signal Transduction/genetics/*immunology | 2 | 2.0 |
Biological Transport | 2 | 0.0 |
Macromolecular Substances | 5 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/metabolism | 3 | 2.0 |
Apoptosis | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Fusion Proteins, bcr-abl/*metabolism | 3 | 8.0 |
Membrane Proteins/metabolism | 3 | 0.0 |
RNA Interference | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
src Homology Domains/genetics | 2 | 3.0 |
*Gene Expression Regulation | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Receptors, IgE/*metabolism | 4 | 11.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 2 | 1.0 |
Signal Transduction/*immunology | 4 | 1.0 |
Receptors, Antigen, B-Cell/immunology/*metabolism | 2 | 18.0 |
Antigens/immunology | 2 | 1.0 |
B-Lymphocytes/*immunology/metabolism | 2 | 4.0 |
Receptors, Antigen, B-Cell/metabolism | 2 | 4.0 |
Signal Transduction/physiology | 3 | 0.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
src-Family Kinases/analysis | 3 | 100.0 |
Cytarabine/*pharmacology | 2 | 5.0 |
HL-60 Cells | 3 | 0.0 |
Catalysis | 2 | 0.0 |
src-Family Kinases/*metabolism/radiation effects | 2 | 100.0 |
1-Phosphatidylinositol 3-Kinase | 5 | 3.0 |
Phosphotransferases (Alcohol Group Acceptor)/metabolism | 2 | 2.0 |
Phosphotyrosine/*metabolism | 2 | 3.0 |
Lymphocytes/*metabolism | 2 | 1.0 |
B-Lymphocytes/*metabolism | 2 | 1.0 |
Peptide Fragments/metabolism | 2 | 0.0 |
Phosphotransferases (Alcohol Group Acceptor)/*metabolism | 2 | 2.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 5 | 2.0 |
*src-Family Kinases | 12 | 28.0 |
Proteins/metabolism | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
Enzyme Precursors/*antagonists & inhibitors | 2 | 33.0 |
Biopsy | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors/metabolism | 2 | 4.0 |
Phosphotyrosine | 3 | 1.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Tyrosine/analogs & derivatives/analysis | 2 | 5.0 |
Protein-Tyrosine Kinase/*genetics | 3 | 1.0 |
Receptors, Antigen, B-Cell/*metabolism | 2 | 2.0 |
Protein-Tyrosine Kinase/chemistry/metabolism | 2 | 12.0 |
src-Family Kinases/chemistry/metabolism | 2 | 66.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Mice, SCID | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Interleukin-2/*pharmacology | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
src-Family Kinases/antagonists & inhibitors/*metabolism | 2 | 11.0 |
